SHYFT Analytics, the leading commercial analytics and real world evidence platform for the life sciences industry is now part of Acorn AI
Analysis, Insight, Action: the latest on COVID-19
Medidata’s customer commitment during COVID-19.
COVID-19 and Clinical Trials: The Medidata Perspective
As the global impact of COVID-19 increases, Medidata is continuously analyzing its effect on patient study enrollment, the response by world regulatory bodies and which Medidata’s solutions can help address your COVID 19-related challenges.
Medidata Positioned as Leader in Everest Group’s “Clinical Development Platform Vendors” PEAK Matrix Assessment for Second Consecutive Year
Medidata, a Dassault Systèmes company, and the global leader in creating end-to-end solutions to support the entire clinical development process, today announced that it has for the second year in a row been named a Leader in the “Clinical Development Platform Vendors PEAK Matrix® Assessment 2020” by Everest Group. The report analyzes the capabilities of life science IT providers focused on clinical trial products, assessing them on vision, capability, and ability to make meaningful market impact.